Central Ohio cancer treatment center treats nearly 600 patients with CyberKnife technology.

1. June 20, 2013
FOR IMMEDIATE RELEASE
CONTACT: Sarah Tiambeng, Zehnder Communications, (504) 962-3731, saraht@z-comm.com
Columbus CyberKnife Celebrates Third Anniversary at Mount Carmel
St. Ann’s
Central Ohio cancer treatment center treats nearly 600 patients with CyberKnife technology
WESTERVILLE, Ohio – This month Columbus CyberKnife completes three years of operations as a
service of Mount Carmel St. Ann’s Hospital. Since opening in 2010, the center has treated hundreds
of patients throughout the region with stereotactic body radiation therapy (SBRT) using CyberKnife®
technology.
Columbus CyberKnife offers the only CyberKnife program in Central Ohio and is one of only three
providers in the state. Patients from across the state have traveled to Columbus CyberKnife to
receive the advanced treatment. Approximately 75 percent of patients have traveled from
communities beyond the hospital’s service area, including neighboring states such as Indiana and
West Virginia.
“The number of patients we’ve treated not only from our area, but also from other parts of the state
and other states, is a testament to our team’s expertise in providing this specialized form of
treatment,” said Dr. Douglas Widman, Columbus CyberKnife medical director.
The CyberKnife treats tumors with precisely focused beams of radiation delivered in five or fewer
procedures. Though the name may summon images of knives or scalpels, CyberKnife treatment
requires no surgery or sedation. CyberKnife has the added ability to track tumors in real time and
adjust for patient movement during treatment, thus minimizing radiation exposure to healthy
surrounding tissue.
Columbus CyberKnife recently celebrated a milestone as a SBRT treatment provider with the
announcement of The American Society of Radiation Oncology’s classification of SBRT as a primary
form of treatment for prostate cancer. The endorsement is a result of long-term clinical trials
supporting the safety and efficacy of SBRT. Outcomes of patients treated with SBRT were shown to
be at least as good as other radiotherapy treatments. Prostate cancer patients account for about 30
percent of cases treated at Columbus CyberKnife.
While tumors in the lung, brain and prostate are most commonly treated at Columbus CyberKnife, the
physician team has also seen an increased number of patients seeking treatment for trigeminal
neuralgia, a debilitating nerve disorder characterized by excruciating facial pain.
“Clinical data has shown SBRT is an effective form of treatment not only for certain types of tumors
throughout the body, but also other conditions such as trigeminal neuralgia,” said Dr. Widman.
“Patients typically experience few to no side effects following treatment due to the highly accurate
nature of the CyberKnife procedure.”

2. A service of Mount Carmel St. Ann’s Hospital, Columbus CyberKnife is located at 495 Cooper Road,
Suite 125 in Westerville, Ohio. For more information, call (614) 898-8300.
###